ARCHIVES

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

Two New Communications Contracts Approved

October 18, 1985

NCAB Opposes Line Item for Centers

May 23, 1980

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977